Co-twin design study of Coomans et al. (2023) included brain imaging markers from all 3 components of the AT(N) framework: amyloid-β (PET), tau (PET), and neurodegeneration as measured with hippocampal volume and CTH in AD vulnerable regions. Here, MAPT is linked to Alzheimer disease.